Codexis (CDXS) Interest Expenses (2010 - 2026)
Codexis (CDXS) posted quarterly Interest Expenses of $40.5 million for Q1 2026, up 3250.41% year-over-year from $1.2 million in Q1 2025, and up 4362.29% quarter-over-quarter from $907000.0 in Q4 2025.
Codexis (CDXS) Interest Expenses (2010 - 2026) Analysis & Trends
Codexis' Interest Expenses history runs 17 years deep, the most recent figure standing at $40.5 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 3250.41% year-over-year to $40.5 million; the TTM figure through Mar 2026 stood at $40.5 million (up 821.31% YoY), while the FY2025 annual figure was $4.9 million, down 96.6% from the prior year.
- Interest Expenses for Q1 2026 stood at $40.5 million, up from $907000.0 in the prior quarter.
- The five-year high for Interest Expenses was $56.0 million in Q2 2022, with the low at $907000.0 in Q4 2025.
- The 5-year median for Interest Expenses is $1.9 million (2023), against an average of $14.4 million.
- The sharpest annual moves came in 2024 and 2025: Interest Expenses tumbled 97.94% in 2024, then soared 3696.7% in 2025.
- Codexis' Interest Expenses stood at $1.8 million in 2022, then surged by 128.84% to $4.2 million in 2023, then sank by 71.98% to $1.2 million in 2024, then decreased by 23.46% to $907000.0 in 2025, then jumped by 4362.29% to $40.5 million in 2026.
- Business Quant data shows CDXS's Interest Expenses at $40.5 million in Q1 2026, $907000.0 in Q4 2025, and $36.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.22 Mn |
| Jun 30, 2026 | 39.22 Mn |
| Mar 31, 2026 | 40.47 Mn |
| Mar 31, 2026 | 40.47 Mn |
| Dec 31, 2025 | 907,000.00 |
| Dec 31, 2025 | 907,000.00 |
| Sep 30, 2025 | 36.75 Mn |
| Sep 30, 2025 | 36.75 Mn |
| Jun 30, 2025 | 37.97 Mn |
| Jun 30, 2025 | 37.97 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.17 Mn |